Overview
Semax is a synthetic peptide based on a fragment of ACTH (4-10) with a Pro-Gly-Pro tail, developed at Moscow State University. It is approved in Russia for stroke recovery, cognitive disorders and optic nerve conditions — and is the nootropic counterpart to selank, with which it is often paired.
Where selank calms, semax sharpens: it is used for focus, memory and mental endurance.
How It Works
Semax strongly upregulates BDNF and NGF in the brain and modulates dopaminergic and serotonergic transmission. Despite being an ACTH fragment, it does not stimulate cortisol release — the hormonal activity was engineered out, leaving the neurotropic melanocortin effects.
Stroke medicine pedigree
Russian clinical use includes ischemic stroke recovery, where its neurotrophic and neuroprotective properties are the rationale. It also increases attention and reduces mental fatigue in studies of healthy people working under demanding conditions.
Key Benefits
Focus and mental endurance — the primary use; documented in Russian studies of operators and shift workers.
Memory consolidation — BDNF-mediated effects on learning.
Neuroprotection — stroke and ischemia applications in Russian clinical practice.
Mood support — mild dopaminergic and serotonergic modulation.
Side Effects & Considerations
Well tolerated intranasally, with occasional nasal irritation, restlessness or insomnia if taken late in the day. The stimulant-like quality is mild but real — morning dosing is standard advice.
Same evidence caveat as selank
The clinical base is entirely Russian, with limited independent replication. Effects in healthy users are reported as noticeable but modest — cleaner concentration, not transformation. The selank-plus-semax combination (calm focus) is the classic Russian stack and the most sensible way to try either. Not approved outside Russia.
Dosage protocols
| Protocol | Dosage | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard (Russian protocol) | 300-600 mcg | 1-2 times daily, morning | 10-14 days, repeatable | Intranasal. Avoid evening dosing — mild stimulating effect can disturb sleep. |
Warnings
Not approved outside Russia. Russian-only evidence base. Morning dosing to protect sleep.